Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study

被引:49
作者
Adeniran, Adebowale J. [1 ]
Theoharis, Constantine [1 ]
Hui, Pei [1 ]
Prasad, Manju L. [1 ]
Hammers, Lynwood [2 ]
Carling, Tobias [3 ]
Udelsman, Robert [3 ]
Chhieng, David C. [1 ]
机构
[1] Yale Univ, Dept Pathol, New Haven, CT 06520 USA
[2] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06520 USA
[3] Yale Univ, Dept Surg, New Haven, CT 06520 USA
关键词
BRAF(V600E) MUTATION; PREOPERATIVE EVALUATION; PAPILLARY CARCINOMAS; V600E MUTATION; DIAGNOSIS; CANCER; NODULES; CLASSIFICATION; PREVALENCE; MANAGEMENT;
D O I
10.1089/thy.2011.0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The BRAF V600E mutation has been reported in 50%-80% of papillary thyroid carcinoma (PTC) cases and is highly specific for PTC. Reflex BRAF testing may improve the diagnostic accuracy of thyroid fine-needle aspiration (FNA) tests having equivocal cytologic interpretations and provide prognostic information that helps guide management in patients with PTC. Patients and Methods: Cases with equivocal thyroid FNA readings (indeterminate and suspicious for PTC) or a positive diagnosis for PTC and concomitant BRAF mutation analysis were included in this prospective study. BRAF mutation analysis was performed by polymerase chain reaction combined with single-strand conformation polymorphism gel electrophoresis using lavage fluid obtained from needle rinsing. The results of histopathologic follow-up were correlated with the cytologic interpretations and BRAF status. Results: One hundred fifty-seven FNAs with equivocal or positive cytologic interpretations were eligible for the study. All but one (99.4%) FNAs were found to have sufficient DNA quality and quantity for the assay. Based on the follow-up diagnosis of nodules after surgical resection, the sensitivity for diagnosing PTC was 63.3% with cytology alone and 80.0% with the combination of cytology and BRAF testing, respectively. No false positives were noted with either cytology or BRAF mutation analysis. All PTCs with extrathyroidal extension and of tall-cell variant were postive for BRAF mutation. Conclusions: BRAF V600E mutation analysis can be easily performed on cytologic preparation using lavage fluids obtained from needle rinsing. By combining morphologic evaluation and BRAF testing, there is a substantial improvement in the preoperative identification of PTC when compared with cytology alone. Patients with equivocal cytologic diagnosis and BRAF V600E mutation are candidates for total thyroidectomy +/- central lymph node dissection.
引用
收藏
页码:717 / 723
页数:7
相关论文
共 43 条
[1]  
Amrikachi M, 2001, ARCH PATHOL LAB MED, V125, P484
[2]  
[Anonymous], MOD PATHOL
[3]   Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules [J].
Boyd, LA ;
Earnhardt, RC ;
Dunn, JT ;
Frierson, HF ;
Hanks, JB .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (05) :494-502
[4]   The National Cancer Institute Thyroid fine-needle aspiration state-of-the-science conference - Inspingtion for a uniform terminology linked to management guidelines [J].
Cibas, Edmund S. ;
Sanchez, Miguel A. .
CANCER CYTOPATHOLOGY, 2008, 114 (02) :71-73
[5]   BRAF mutation in papillary thyroid carcinoma [J].
Cohen, J ;
Xing, MZ ;
Mambo, E ;
Guo, ZM ;
Wu, GG ;
Trink, B ;
Beller, U ;
Westra, WH ;
Ladenson, PW ;
Sidransky, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) :625-627
[6]   Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid:: A potential application for the preoperative assessment of thyroid nodules [J].
Cohen, Y ;
Rosenbaum, E ;
Clark, DP ;
Zeiger, MA ;
Umbricht, CB ;
Tufano, RP ;
Sidransky, D ;
Westra, WH .
CLINICAL CANCER RESEARCH, 2004, 10 (08) :2761-2765
[7]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[8]   BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma [J].
Costa, Angela M. ;
Herrero, Agustin ;
Fresno, Manuel F. ;
Heymann, Jonas ;
Antonio Alvarez, Jose ;
Cameselle-Teijeiro, Jose ;
Garcia-Rostan, Ginesa .
CLINICAL ENDOCRINOLOGY, 2008, 68 (04) :618-634
[9]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[10]   Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma [J].
Domingues, R ;
Mendonça, E ;
Sobrinho, L ;
Bugalho, MJ .
CYTOPATHOLOGY, 2005, 16 (01) :27-31